The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
|Videos|March 24, 2020
Why Flu Season Has Been Severe
Author(s)Contagion® Editorial Staff
Tina Q. Tan, MD, discusses the particular severity of the ongoing flu season.
Advertisement
Segment Description: Tina Q. Tan, MD, professor of pediatrics at the Feinberg School of Medicine, Northwestern University, discusses the particular severity of the ongoing flu season.
Interview Transcript (modified slightly for readability):
Tan: Part of what's causing the severity has to do with the influenza virus strains that are circulating. This is a bit of an unusual year in that we started very early. Flu started circulating at the end of September. We also started with a different flu strain that usually circulates first. We started with an influenza B strain. Later in December, we had an influenza A strain that started circulating. Now both viruses are circulating pretty much equally. However, there has been a second wave of disease that has started after the new year and it's been particularly severe in children.
In order to prevent illness, be vaccinated. For those individuals who have not been vaccinated, it is still not too late to get a vaccine.
Advertisement
Related to this article
UTI guidelines are moving away from complicated or uncomplicated infections to localized or systemic classification terminologies. Guidelines author Zachary Nelson, PharmD, MPH, BCIDP, provides further insights on the changes including applying antibiograms, potential costs, and whether clinicians will embrace these new classifications.
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate met every prespecified primary immunogenicity and safety endpoint against PCV20 and PCV21 in the OPUS-1 trial of 4,047 US adults.
Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
Lori Handy, MD, provides guidance in these areas, including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
Advertisement
Advertisement
Trending on Contagion Live
1
Ebola Update: DRC Outbreak Passes 8,700 Cases and 4,200 Deaths
2
FDA Approves Pritelivir for Refractory HSV in Immunocompromised Adults
3
Active Outbreaks Tied to Sprouts, Cheese and Turtles
4
Measles Update: October 9, 2026
5